Singapore markets close in 3 hours 15 minutes

SIGA Technologies, Inc. (SIGA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.31+0.53 (+6.09%)
At close: 04:00PM EDT
9.32 +0.01 (+0.05%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.78
Open8.78
Bid9.30 x 100
Ask9.33 x 100
Day's range8.78 - 9.43
52-week range4.22 - 10.00
Volume678,372
Avg. volume843,613
Market cap662.506M
Beta (5Y monthly)0.97
PE ratio (TTM)9.81
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date25 Mar 2024
1y target estN/A
All
News
  • GlobeNewswire

    SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

    NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, May 7, 2024. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at www.siga.com under the 'Even

  • GlobeNewswire

    SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

    NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious disease, announced today that it entered into an amendment to its international promotion agreement with Meridian Medical Technologies, Inc. (Meridian). Effective June 1, SIGA will drive international promotion activities for oral TPOXX® while maintaining its contractual relationship with Meridian to maintain continuity for key c

  • GlobeNewswire

    SIGA Names Larry Miller General Counsel

    NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the appointment of Larry Miller as general counsel, effective today. “With over twenty years of experience in the biopharmaceutical industry, Larry brings a proven track record of growing commercial businesses, successful mergers and acquisitions, and strong corporate governance, which are critical to driving